Skip to content

Ginkgo Bioworks DNA Gross Profit

Gross Profit at other companies

TEC
Bio-TechneTECH
$208.29M-2.9%
Azenta logo
AzentaAZTA
$62.04M-1.2%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$33.7M+336%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
Danaher logo
DanaherDHR
$3.59B+2.3%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Calculated from Ginkgo Bioworks’s reported figures.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's gross profit?
Ginkgo Bioworks (DNA) reported gross profit of $16.38M in Q1 2026.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.